Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ
An exceptionally low initiation rate was observed even in this potentially advantaged population suggests GLP-1 RA initiation rates in the broader Polish population may be equally concerning, if not worse
This potentially leads to limitations in GLP-1 receptor agonist use in patients who are unwilling or unable to administer these medications subcutaneously
Most people find relief through simple lifestyle adjustments: staying well-hydrated, gradually increasing fiber intake, incorporating regular physical activity, and establishing consistent bathroom routines
The endocannabinoid system as an emerging target of pharmacotherapy
However, an anabolizing agent such as GLP1-RAs can also upregulate the AMPK-pathway, due to cAMP accumulation ( Figure 1 )